KW-8232 free base

Modify Date: 2025-08-25 18:23:56

KW-8232 free base Structure
KW-8232 free base structure
Common Name KW-8232 free base
CAS Number 170365-25-0 Molecular Weight 609.16
Density N/A Boiling Point N/A
Molecular Formula C36H37ClN4O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of KW-8232 free base


KW-8232 free base is an anti-osteoporotic agent, and can reduces the biosynthesis of PGE2.

 Names

Name KW-8232 free base

 KW-8232 free base Biological Activity

Description KW-8232 free base is an anti-osteoporotic agent, and can reduces the biosynthesis of PGE2.
Related Catalog
Target

Prostaglandin Receptor[1]

In Vitro KW-8232 free base is an anti-osteoporotic agent. KW-8232 reduces the biosynthesis of PGE2 in mouse osteoblastic cells[1].
In Vivo KW-8232 (3, 10, 30 mg/kg, p.o.) potently increases the femoral bone mineral density (BMD) of immobilized legs of rats, and affects immobilization-induced abnormal bone turnovrer. KW-8232 markedly decreases urinary calcium excreation in the neurectomized rats only at 30 mg/kg, and highly reduces urinary pyridinoline and deoxypyridionline excretion which are markers of bone resorption in neurectomized rats. KW-8232 inhibits bone loss may be attributed to the lower prostaglandins (PGs)-stimulated bone resorption via regulation of PGE2 production[1].
Animal Admin After male Sprague-Dawley rats (5-week-old) are anesthetized with sodium pentobarbital (30 mg/kg, i.p.), a dorsolateral incision is made on the right hip through which the sciatic nerve is exposed, and a 0.5-cm section is excised. The contralateral leg is left intact. KW-8232 is dissolved in distilled water and administered orally at 1, 3, 10, and 30 mg/kg once daily beginning 1 day prior to neurectomy. On day 28, rats are exsanguinated under diethyl ether agter obtaining urine, and their femurs are removed. Bone mineral density (BMD) is determined by dual energy x-ray absorptiometry. Twenty-four hour urine samples are collected from the animals, which are fasted immediately after the final administration of KW-8232[1].
References

[1]. Uchii M, et al. Effect of KW-8232, a novel anti-osteoporotic agent, on bone loss in sciatic neurectomized rats. Jpn J Pharmacol. 1998 Oct;78(2):241-3.

 Chemical & Physical Properties

Molecular Formula C36H37ClN4O3
Molecular Weight 609.16
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.